DNLI
$17.61-3.98%
Denali Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%Russell 3000 0.005%US Stock Market 0.005%
Denali Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Denali Therapeutics Inc. total returns by year (2018–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $16.51 | $17.61 | 0.0% | +6.7% | |
| 2025 | $20.38 | $16.51 | 0.0% | -19.0% | |
| 2024 | $21.46 | $20.38 | 0.0% | -5.0% | |
| 2023 | $27.81 | $21.46 | 0.0% | -22.8% | |
| 2022 | $44.60 | $27.81 | 0.0% | -37.6% | |
| 2021 | $83.76 | $44.60 | 0.0% | -46.8% | |
| 2020 | $17.42 | $83.76 | 0.0% | +380.8% | |
| 2019 | $20.66 | $17.42 | 0.0% | -15.7% | |
| 2018 | $15.64 | $20.66 | 0.0% | +32.1% |
- Annualized
- +1.4%
- 2018–2026
- Average year
- +33.2%
- 8 full years
- Best year
- +380.8%
- 2020
- Worst year
- -46.8%
- 2021
- Positive years
- 2/8
- 25% up
Annualized (CAGR)
+1.4%
2018–2026
Average year
+33.2%
8 full years
Best year
+380.8%
2020
Worst year
-46.8%
2021
Positive years
2/8
25% up
Total return by period#
Annual
-200%0%200%
2018+32%'18
2019-16%'19
2020+381%'20
2021-47%'21
2022-38%'22
2023-23%'23
2024-5.0%'24
2025-19%'25
2026+6.7%'26
Methodology#
Total returns, dividends reinvested, measured on DNLI. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Denali Therapeutics Inc.'s average annual return?
- Since 2018, Denali Therapeutics Inc. (DNLI) has returned about 1.4% a year (the compound annual growth rate) and an average calendar-year return of 33.2%.
- What were Denali Therapeutics Inc.'s best and worst years?
- Over 2018–2026, the best year was 2020 (+380.8%) and the worst was 2021 (-46.8%).
- How often is Denali Therapeutics Inc. up in a year?
- 2 of the 8 full years since 2018 were positive — about 25% of the time.
More on Denali Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100